Use of Direct Oral Anticoagulation Therapy Following Implantation of the Watchman Left Atrial Appendage Occlusion Device
| Autor: | Joseph Aragon, Colin Shafer, Michael Shenoda, Benita Tjoe, Brett A. Gidney, Hoang Nguyen, Gregory Cogert, Jing Li, Samantha Yim, Caleb Thompson, Jessica Quintos, Sri Mandava |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Aspirin
medicine.medical_specialty Standard of care business.industry medicine.medical_treatment Warfarin Atrial fibrillation medicine.disease Left atrial appendage occlusion Internal medicine medicine Cardiology cardiovascular diseases Cardiology and Cardiovascular Medicine business Oral anticoagulation medicine.drug |
| Zdroj: | Structural Heart. 5:295-301 |
| ISSN: | 2474-8706 |
| Popis: | Background: Previously, the standard of care following left atrial appendage occlusion (LAAO) with the Watchman device (Boston Scientific) was 45 days of warfarin and aspirin followed by dual antip... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|